Acadian Asset Management’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABOS
Acadian Asset Management's ABOS Position: Q3 2026 in Review
Acadian Asset Management increased its Acumen Pharmaceuticals (ABOS) stake by 26% in Q3 2026, buying an estimated $185K and bringing the position to 341,825 shares worth $754K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.
Acadian Asset Management first reported a position in ABOS in Q4 2022 and has held it in 8 quarters since. 92 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.
- Acadian Asset Management held 341,825 shares of Acumen Pharmaceuticals worth $754K as of Q3 2026.
- Acadian Asset Management bought 71,487 Acumen Pharmaceuticals shares in Q3 2026, an estimated $185K.
- Acumen Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q3 2026, its #1322 holding.
- Acadian Asset Management first reported a position in Acumen Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
- 92 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.
Based on Acadian Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.